These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20923260)

  • 1. Novel therapeutic strategies targeting vascular endothelium in essential hypertension.
    Tousoulis D; Papageorgiou N; Androulakis E; Paroutoglou K; Stefanadis C
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1395-412. PubMed ID: 20923260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-hypertensive drugs associated with the improvement of endothelial function].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2004 Jan; 62(1):128-34. PubMed ID: 14737845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial function and arterial hypertension].
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():85S-90S. PubMed ID: 8562274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C; Richard V
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in essential hypertension.
    Panza JA
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-26-33. PubMed ID: 9422849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium antagonists and endothelial function].
    Yasuda O; Kawamoto H; Yokoi T; Rakugi H; Ogihara T
    Clin Calcium; 2005 Oct; 15(10):1663-8. PubMed ID: 16199912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of statins in endothelial dysfunction in hypertension.
    Sarkar K; Sinha AK; Mehta JL
    Curr Opin Cardiol; 2006 Jul; 21(4):316-21. PubMed ID: 16755200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the arterial wall, but what is the target?
    Shantsila E; Lim HS
    J Hum Hypertens; 2009 Jan; 23(1):1-3. PubMed ID: 18509342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endothelial ion channels -- novel targets for antihypertensive therapy].
    Maier T; Grgic I; Busch C; Hoyer J; Köhler R
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2637-9. PubMed ID: 16281159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 16. Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics.
    Highlander P; Shaw GP
    Ther Adv Cardiovasc Dis; 2010 Feb; 4(1):43-54. PubMed ID: 19965897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function as intermediary endpoint in hypertension: comments.
    Kiowski W
    Blood Press Suppl; 1997; 2():71-5. PubMed ID: 9495631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells: biology and therapeutic potential in hypertension.
    van Zonneveld AJ; Rabelink TJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):167-72. PubMed ID: 16481884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytoprotection of the endothelium cells in primary hypertension].
    Kwiecień J
    Pol Merkur Lekarski; 1998 Sep; 5(27):151-4. PubMed ID: 10101484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.